Travere Therapeutics Inc (NASDAQ:TVTX)

Delayed Data
As of Dec 08
 -0.01 / -0.12%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Travere Therapeutics Inc have a median target of 12.00, with a high estimate of 23.00 and a low estimate of 8.00. The median estimate represents a +38.89% increase from the last price of 8.64.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Travere Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -152.24%
Growthannually 4.12%


Growthquarterly 87.02%
Growthannually 9.70%
Key to the earnings and sales forecast charts.